Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.853,65
0,19%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Mallinckrodt plc (MNK) Mallinckrodt plc (MNK) Notizie

MNK

Mallinckrodt (MNK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MNK
DataOraFonteTitoloSimboloCompagnia
29/08/202313:22IH Market NewsTuesday’s Wall Street Highlights: Alphabet, Verizon, Joann, Intel, Catalent, and moreAMEX:MNKMallinckrodt plc
28/08/202310:46PR Newswire (US)Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid ObligationsAMEX:MNKMallinckrodt plc
23/08/202314:32PR Newswire (US)Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring PlanAMEX:MNKMallinckrodt plc
09/08/202312:45PR Newswire (US)Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year GuidanceAMEX:MNKMallinckrodt plc
15/06/202312:52PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023AMEX:MNKMallinckrodt plc
13/06/202308:30PR Newswire (US)Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant PatientsAMEX:MNKMallinckrodt plc
01/06/202312:52PR Newswire (US)Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023AMEX:MNKMallinckrodt plc
09/05/202312:45PR Newswire (US)Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year GuidanceAMEX:MNKMallinckrodt plc
08/05/202312:52PR Newswire (US)Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023AMEX:MNKMallinckrodt plc
05/05/202312:52PR Newswire (US)Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact AwardsAMEX:MNKMallinckrodt plc
28/04/202314:00Business WireBuxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment SchemeAMEX:MNKMallinckrodt plc
24/04/202312:45PR Newswire (US)Mallinckrodt to Report Earnings Results for First Quarter 2023AMEX:MNKMallinckrodt plc
10/04/202312:53PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)AMEX:MNKMallinckrodt plc
21/03/202311:53PR Newswire (US)Mallinckrodt to Present New Retrospective Data on Effect of Acthar® Gel (Repository Corticotropin Injection) to Reduce Corticosteroid Use and Burden for Advanced Sarcoidosis at the Academy of Managed Care Pharmacy (AMCP) 2023 Annual MeetingAMEX:MNKMallinckrodt plc
09/03/202309:00PR Newswire (US)Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)AMEX:MNKMallinckrodt plc
28/02/202312:45PR Newswire (US)Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 GuidanceAMEX:MNKMallinckrodt plc
16/02/202314:03PR Newswire (US)Mallinckrodt to Present at Cowen's 43rd Annual Health Care ConferenceAMEX:MNKMallinckrodt plc
08/02/202312:45PR Newswire (US)Mallinckrodt to Report Earnings Results for Fourth Quarter 2022AMEX:MNKMallinckrodt plc
22/01/202320:00PR Newswire (US)Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care CongressAMEX:MNKMallinckrodt plc
16/11/202212:52PR Newswire (US)Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator AwardAMEX:MNKMallinckrodt plc
08/11/202212:45PR Newswire (US)Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms GuidanceAMEX:MNKMallinckrodt plc
01/11/202211:53PR Newswire (US)Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2022 Scientific MeetingAMEX:MNKMallinckrodt plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:MNK

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TITR
Telecom Italia
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
PIRC
Pirelli & C
BIT
SPM
Saipem
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network